We Can Medicines Statistics

Total Valuation

TPEX:6929 has a market cap or net worth of TWD 1.44 billion. The enterprise value is 2.37 billion.

Market Cap	1.44B
Enterprise Value	2.37B

Important Dates

The next estimated earnings date is Thursday, May 15, 2025.

Earnings Date	May 15, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:6929 has 44.97 million shares outstanding. The number of shares has increased by 2.86% in one year.

Current Share Class	n/a
Shares Outstanding	44.97M
Shares Change (YoY)	+2.86%
Shares Change (QoQ)	+1.12%
Owned by Insiders (%)	0.61%
Owned by Institutions (%)	1.17%
Float	5.43M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.44
PB Ratio	1.29
P/TBV Ratio	1.30
P/FCF Ratio	7.31
P/OCF Ratio	5.52
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.24, with an EV/FCF ratio of 12.07.

EV / Earnings	-50.33
EV / Sales	0.73
EV / EBITDA	9.24
EV / EBIT	n/a
EV / FCF	12.07

Financial Position

The company has a current ratio of 1.59, with a Debt / Equity ratio of 1.11.

Current Ratio	1.59
Quick Ratio	0.57
Debt / Equity	1.11
Debt / EBITDA	4.83
Debt / FCF	6.31
Interest Coverage	-1.82

Financial Efficiency

Return on equity (ROE) is -4.88% and return on invested capital (ROIC) is -1.39%.

Return on Equity (ROE)	-4.88%
Return on Assets (ROA)	-1.05%
Return on Invested Capital (ROIC)	-1.39%
Return on Capital Employed (ROCE)	-2.31%
Revenue Per Employee	3.25M
Profits Per Employee	-46,941
Employee Count	1,005
Asset Turnover	1.10
Inventory Turnover	2.67

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -56.10% in the last 52 weeks. The beta is -0.47, so TPEX:6929's price volatility has been lower than the market average.

Beta (5Y)	-0.47
52-Week Price Change	-56.10%
50-Day Moving Average	39.21
200-Day Moving Average	46.94
Relative Strength Index (RSI)	32.13
Average Volume (20 Days)	19,818

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6929 had revenue of TWD 3.27 billion and -47.18 million in losses. Loss per share was -1.09.

Revenue	3.27B
Gross Profit	1.10B
Operating Income	-50.01M
Pretax Income	-48.29M
Net Income	-47.18M
EBITDA	18.40M
EBIT	-50.01M
Loss Per Share	-1.09

Full Income Statement

Balance Sheet

The company has 305.67 million in cash and 1.24 billion in debt, giving a net cash position of -935.62 million or -20.81 per share.

Cash & Cash Equivalents	305.67M
Total Debt	1.24B
Net Cash	-935.62M
Net Cash Per Share	-20.81
Equity (Book Value)	1.12B
Book Value Per Share	24.88
Working Capital	543.24M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 260.68 million and capital expenditures -63.95 million, giving a free cash flow of 196.73 million.

Operating Cash Flow	260.68M
Capital Expenditures	-63.95M
Free Cash Flow	196.73M
FCF Per Share	4.37

Full Cash Flow Statement

Margins

Gross margin is 33.54%, with operating and profit margins of -1.53% and -1.44%.

Gross Margin	33.54%
Operating Margin	-1.53%
Pretax Margin	-1.48%
Profit Margin	-1.44%
EBITDA Margin	0.56%
EBIT Margin	-1.53%
FCF Margin	6.02%

Dividends & Yields

This stock pays an annual dividend of 0.27, which amounts to a dividend yield of 0.85%.

Dividend Per Share	0.27
Dividend Yield	0.85%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-2.86%
Shareholder Yield	-2.01%
Earnings Yield	-3.28%
FCF Yield	13.67%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:6929 has an Altman Z-Score of 2.09. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.09
Piotroski F-Score	n/a